SCHEMBL845534

SCHEMBL845534

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)C3CC3)cc2)cc1)[C@@H]1CCCN1C(=O)Cc1cccnc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TRPV1 Q8NER1 1/20 0.42
ITGB1 P05556 2/20 0.41
ITGA4 P13612 2/20 0.41
PAX8 Q06710 1/20 0.41
FKBP1A P62942 1/20 0.41
HCRTR1 O43613 2/20 0.41
HCRTR2 O43614 2/20 0.41
ATM Q13315 1/20 0.41
VNN1 O95497 1/20 0.41
KMT2A Q03164 1/20 0.41
ACE P12821 1/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
NAMPT P43490 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845191 0.92 HRH3 (0.52) HRH3ALDH1A1TRPV1PAX8FKBP1A
SCHEMBL845401 0.91 ALDH1A1 (0.45) HRH3ALDH1A1TRPV1ITGB1ITGA4
SCHEMBL845712 0.89 HRH3 (0.50) HRH3ALDH1A1ITGB1ITGA4PAX8
SCHEMBL845015 0.85 ALDH1A1 (0.42) HRH3ALDH1A1ITGB1ITGA4PAX8
SCHEMBL15116902 0.84 VNN1 (0.44) ALDH1A1PAX8FKBP1AVNN1ACE
SCHEMBL16359563 0.84 VNN1 (0.44) ALDH1A1PAX8FKBP1AVNN1ACE
SCHEMBL845723 0.84 ALDH1A1 (0.51) ALDH1A1ITGB1ITGA4FKBP1AHCRTR1
SCHEMBL18887502 0.84 HIF1A (0.48) HRH3ALDH1A1TRPV1PAX8FKBP1A
SCHEMBL845171 0.84 ALDH1A1 (0.53) ALDH1A1ITGB1ITGA4FKBP1AHCRTR1
SCHEMBL845375 0.84 MAPK1 (0.46) ALDH1A1ATMKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed